Australia markets close in 4 hours 33 minutes

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.77+0.60 (+9.72%)
At close: 04:00PM EST
6.73 -0.04 (-0.59%)
After hours: 07:38PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 51.25B
Enterprise value 31.02B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)7.36
Price/book (mrq)12.48
Enterprise value/revenue 38.02
Enterprise value/EBITDA 7-19.71

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 310.77%
S&P500 52-week change 324.47%
52-week high 310.88
52-week low 34.72
50-day moving average 35.81
200-day moving average 36.62

Share statistics

Avg vol (3-month) 32.46M
Avg vol (10-day) 37.57M
Shares outstanding 5202.62M
Implied shares outstanding 6N/A
Float 8168.4M
% held by insiders 10.43%
% held by institutions 188.40%
Shares short (14 Nov 2021) 410.43M
Short ratio (14 Nov 2021) 46.16
Short % of float (14 Nov 2021) 45.80%
Short % of shares outstanding (14 Nov 2021) 45.15%
Shares short (prior month 14 Oct 2021) 417.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin -55.41%
Operating margin (ttm)-42.33%

Management effectiveness

Return on assets (ttm)-12.40%
Return on equity (ttm)-413.68%

Income statement

Revenue (ttm)127.66M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)-49.40%
Gross profit (ttm)17.71M
EBITDA -51.95M
Net income avi to common (ttm)-70.74M
Diluted EPS (ttm)-0.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)245.76M
Total cash per share (mrq)1.21
Total debt (mrq)19.4M
Total debt/equity (mrq)25.17
Current ratio (mrq)2.42
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-115.01M
Levered free cash flow (ttm)-8.53M